Ares-backed pharma-services provider Alcami explores sale


Ares Capital, Alcami, pharmaceutical services, private equity, merger, M&A
Photo courtesy of scanrail/iStock/Getty Images
  • Ares inherited Alcami via acquisition of American Capital
  • ~8 parties said to move forward in second round
  • Pharma-services firm expected to trade for >12x Ebitda
Alcami, whose outsourced drug-development services help pharma and biotech companies more quickly bring new products to market, is in the midst of a sales process, Buyouts has learned. William Blair is conducting the auction for the contract development and manufacturing ...

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.

Digital Edition

To read a digital copy of our latest magazine

click here

PE News Briefs